Some of the clinical characteristics of Crohn disease of the head and neck overlap those of squamous cell carcinoma of the head and neck. We describe the diagnostic and therapeutic complexities we encountered in an unusual case of piriform sinus cancer that had arisen in a field of pharyngeal Crohn disease. Based on our initial failure to recognize the predominant inflammatory component of the lesion, we discuss the special considerations that must be made for the detection, staging, and management of head and neck cancer in Crohn disease patients. We further describe the multiple potential interactions among smoking, inflammation, and immunosuppression therapy in the colocalized pathogenesis of the two disease states.
Introduction
Crohn disease is an idiopathic chronic inflammatory disorder of the gastrointestinal tract that exhibits a spectrum of clinical presentations. It is characterized by noncontiguous, transmural inflammation with noncaseating granulomas anywhere in the gastrointestinal tract, and it frequently results in intestinal wall fibrosis, strictures, and fistulas. Extraintestinal involvement of Crohn disease is well described; it can present as oral ulcers, hepatobiliary disease, arthritis, uveitis, dermatologic manifestations, and metabolic bone disease. 1 Mucosal involvement in the head and neck is unusual, but it has been described in the oral cavity, pharynx, cervical esophagus, nasal cavity, orbit, and middle ear. 2, 3 Crohn disease rarely involves the larynx, as only 13 cases of laryngeal Crohn disease have been reported in the literature. 4 In this article, we describe an unusual case of squamous cell carcinoma (SCC) arising in a background of laryngeal dysfunction that was initially thought to be caused by the malignancy but that ultimately proved to be related to Crohn disease. The challenges we encountered in diagnosis, staging, and therapeutic decision making illustrate previously undescribed considerations for the evaluation and management of suspected head and neck SCC (HNSCC) in a patient with Crohn disease. We further speculate on the potential relationship between the pathologies of the two diseases.
Case report
A 67-year-old man, a smoker, had undergone a tracheostomy at another hospital after he had presented with a 3-month history of progressive odynophagia, hoarseness, dyspnea, and aspiration. The patient was then transferred to our center. Office endoscopic evaluation and computed tomography (CT) identified an exophytic mass at the base of the right piriform sinus that was associated with distortion of the right supraglottic anatomy that obscured the glottic airway (figure, A).
The patient's medical history was notable for a diagnosis of stricturing Crohn disease of the ascending colon 7 years earlier. This disease was controlled with mesalamine, and the patient reported no recent exacerbations or extraintestinal manifestations.
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Examination with the patient under general anesthesia found the mass arising from the right medial piriform sinus, with its superior border located just below the aryepiglottic fold. In addition, an ulcer at the lower border of the mass extended inferiorly across the piriform apex into the upper postcricoid mucosa, where exposed and eroded cricoid cartilage was seen.
Sclerotic changes in the arytenoid and cricoid cartilages on contrast-enhanced CT (figure, B) corresponded to a fixed right true vocal fold on examination. A focal biopsy of the exophytic component of the mucosal changes indicated that the lesion was an SCC. Based on the observed cricoid cartilage erosion, the lesion was categorized as a T4aN0M0 SCC of the piriform sinus.
The diagnosis of a locally advanced piriform sinus HNSCC combined with observed severe laryngeal dysfunction supported a recommendation for a total laryngectomy, which was performed with an ipsilateral hemithyroidectomy, staging neck dissection, and paratracheal node dissection. Intraoperatively, a previously unrecognized extension of the ulceration from the piriform sinus to the midline posterior pharyngeal wall was observed, raising concern for the need to perform an unplanned circumferential pharyngectomy and reconstruction. However, a frozen-section biopsy of the area identified only chronic inflammation. Therefore, this portion of the ulcer was not resected but became part of the primary mucosal closure.
Gross examination of the laryngectomy specimen revealed a 2-cm exophytic mass in the superior half of the right medial piriform sinus. Its inferior margin did not involve the lower piriform sinus but abutted a large ulcer extending to the piriform apex and upper postcricoid mucosa.
Pathologic analysis of the exophytic mass identified a circumscribed, moderately differentiated SCC with a pushing invasion pattern (figure, C) with no involvement of the laryngeal skeleton. The changes at the level of the cricoid cartilage were instead made up of extensive fibrosis and sinus tracts that eroded the cricoid cartilage and contained no malignant cells (figure, D). Similarly, the mucosal ulceration in the inferior half of the piriform sinus contained only granulation tissue and a chronic inflammatory infiltrate (figure, E).
In contrast to the limited tumor, the widespread inflammation and fibrosis appeared to underlie the distorted, immobile hemilarynx. Such findings strongly suggested that it was the Crohn disease and not the HNSCC that was the dominant laryngeal destructive process that led to the patient's initial presentation with airway compromise. Thus, a final pathologic clas-sification of T2N0M0 was assigned, and no adjuvant therapy was given.
Despite the fact that the ulceration at the mucosal closure of the neopharynx remained unresected, the patient's postoperative course was uncomplicated by fistula, and the ulcer resolved without any changes to his Crohn disease management. He remained cancer-free during almost 4 years of follow-up, when he died of a cause unknown to us.
Discussion
Extraintestinal manifestations of Crohn disease may appear as the initial presentation of the disease or Managing head and neck MalignancY arising in a field of crohn disease inflaMMation: report of a case they may arise at any time during the disease course. The prevalence of extraintestinal manifestations in patients with Crohn disease has been reported to be 35%, with the most common being peripheral arthritis, sacroiliitis, erythema nodosum, pyoderma gangrenosum, primary sclerosing cholangitis, iritis, uveitis, and deep venous thrombosis. 5, 6 Laryngeal involvement is exceedingly rare; when it does occur, it can manifest as ulcerative lesions of the epiglottis, arytenoid cartilage and mucosa, and laryngeal vestibule with associated edema. 2 Symptoms of laryngeal involvement of Crohn disease include pain, swallowing dysfunction, hoarseness, and occasionally airway compromise. Like intestinal Crohn disease lesions, head and neck mucosal Crohn disease lesions are diverse in appearance, variably containing chronic inflammation, noncaseating granulomas, ulceration, granulation tissue, and/or fibrosis on histologic examination. 1 Our case represents an unusual instance of HNSCC arising in a field of Crohn-disease-related mucosal inflammation. We report it to illustrate the overlap between the clinical and radiologic presentations of laryngeal Crohn disease and malignancy, which confounded our initial diagnosis, staging, and treatment planning. Specifically, in our initial evaluation, we failed to recognize that the HNSCC was actually an early-stage cancer that had arisen in a wider field of Crohn inflammation, which was primarily responsible for the laryngeal dysfunction. In this context, fixation of the true vocal fold is described here as an unusual extraintestinal sequela of Crohn disease that arose from the inflammation and fibrosis of the cricoarytenoid joint and paraglottic musculature.
Although irreversible Crohn-disease-related laryngeal dysfunction might still justify a total laryngectomy, our case illustrates how an initially incorrect staging of a malignancy in the context of head and neck Crohn disease could lead to overtreatment. Accordingly, our case demonstrates the need to suspect, identify, and fully delineate any coincident inflammatory lesions when evaluating HNSCC in any patient with known Crohn disease. Moreover, large or multifocal head and neck mucosal abnormalities indicative of an extraintestinal manifestation of Crohn disease may also warrant extensive mapping biopsies to rule out coincident malignancy.
Active Crohn disease in the same field as an HN-SCC has the potential to complicate both surgery and adjuvant radiation. In our case, the dynamic nature of the Crohn disease component was confused intraoperatively with local tumor progression and raised concern for the need for an unplanned total pharyngeal resection with reconstruction. Upon recognizing that the expanded lesion was inflammatory in nature, the ulcerated mucosa was included in the primary closure without complication, obviating the need for a more extensive resection.
The known adverse sequelae of elective intestinal surgery during Crohn disease exacerbations include intractable fistula or stricture. Thus, the practice of first abating the acute intestinal exacerbations medically before surgery 7 may also have relevance to head and neck extraintestinal manifestations.
Crohn disease patients also experience acute and late toxicities from abdominal or pelvic radiotherapy, which might indicate the potential for similar effects during primary or adjuvant head and neck radiation. Willett et al reported that 30% of Crohn disease patients who underwent irradiation for abdominal or pelvic neoplasms experienced exacerbations of Crohn disease symptoms that limited the planned course of therapy, with the worst toxicity occurring in patients with active Crohn disease. 8 In our case, carefully distinguishing malignant from inflammatory pathologies in the surgical specimen proved to be important for downstaging and thus avoiding radiotherapy without compromising the oncologic outcome.
The smoking history of our patient raises the possibility that the spatial colocalization of the two lesion types was entirely coincidental. However, smoking does exacerbate the disease course of intestinal Crohn disease; Johnson et al reported that smoking cessation reduced the frequency of Crohn disease exacerbations by 65%. 9 Thus it is very plausible that our patient's direct exposure to tobacco smoke contributed to the development of extraintestinal Crohn disease in the same mucosal field as the HNSCC. We also speculate that either extraintestinal Crohn disease or its therapies can serve as cofactors contributing to HNSCC carcinogenesis and progression.
Notably, Crohn disease is a known risk factor for colorectal cancer as well as cancer of the small intestine; it is associated with a relative risk of 1.9 and 21.1 to 27.1, respectively. 6 Moreover, Crohn disease also raises the risk of multiple other malignancies, including cutaneous SCCs and urothelial carcinomas, with a standardized incidence ratio of 2.4 and 2.0, respectively. 6 A recent case series by Katsanos et al 10 also suggested an increased risk for oral cancer, although no Crohn disease patients in their series exhibited any oral involvement as an extraintestinal manifestation.
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The mechanisms of carcinogenesis in patients with Crohn disease are incompletely understood, but they appear to be linked to both long-standing inflammation and therapeutic immunosuppression. Some treatment-related malignancies may arise from the use of thiopurine drugs, which are associated with urinary and hematologic malignancies as well as nonmelanoma skin cancers. 11 In conclusion, our case demonstrates the need for an exhaustive initial clinical and pathologic assessment for suspected HNSCC in patients with a history of Crohn disease, even in the absence of known extraintestinal manifestations. Both surgery and radiotherapy for HNSCC likely carry additional risks in patients with active Crohn disease in the same mucosal field. Our case also highlights the potential interactions among cigarette smoke, head and neck Crohn disease, and immunosuppression therapy that may contribute to a spatial association between the two disease states.
